BTIG Reiterates Buy on Enovis, Maintains $39 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.5%

Neg 0% Neu 90.5% Pos 0%

BTIG analyst Ryan Zimmerman reiterates Enovis (NYSE:ENOV) with a Buy and maintains $39 price target.

Comments

No comments yet. Be the first!